Churchill Capital Corp IX Warrant (CCIXW) - Net Assets
Based on the latest financial reports, Churchill Capital Corp IX Warrant (CCIXW) has net assets worth $297.54 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($307.78 Million) and total liabilities ($10.24 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check CCIXW financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $297.54 Million |
| % of Total Assets | 96.67% |
| Annual Growth Rate | 22009.56% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 2391432.55 |
Churchill Capital Corp IX Warrant - Net Assets Trend (2023–2025)
This chart illustrates how Churchill Capital Corp IX Warrant's net assets have evolved over time, based on quarterly financial data. Also explore Churchill Capital Corp IX Warrant (CCIXW) total assets for the complete picture of this company's asset base.
Annual Net Assets for Churchill Capital Corp IX Warrant (2023–2025)
The table below shows the annual net assets of Churchill Capital Corp IX Warrant from 2023 to 2025. For live valuation and market cap data, see Churchill Capital Corp IX Warrant (CCIXW) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $297.54 Million | +2.96% |
| 2024-12-31 | $288.99 Million | +4782868.06% |
| 2023-12-31 | $6.04K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Churchill Capital Corp IX Warrant's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1005560000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $307.62 Million | 103.39% |
| Total Equity | $297.54 Million | 100.00% |
Churchill Capital Corp IX Warrant Competitors by Market Cap
The table below lists competitors of Churchill Capital Corp IX Warrant ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ortivus AB ser. B
ST:ORTI-B
|
$14.04 Million |
|
Herkules S.A.
WAR:HRS
|
$14.04 Million |
|
Akritas S.A
AT:AKRIT
|
$14.04 Million |
|
Asturiana de Laminados S.A.
MC:ELZ
|
$14.04 Million |
|
Maming Enam Sembilan Mineral Tbk PT
JK:AKSI
|
$14.01 Million |
|
Tong Hua Holding Public Company Limited
BK:TH
|
$14.00 Million |
|
Ata Gayrimenkul Yatirim Ortakligi AS
IS:ATAGY
|
$14.00 Million |
|
Zivo Bioscience Inc
NASDAQ:ZIVO
|
$14.00 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Churchill Capital Corp IX Warrant's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 288,986,930 to 297,543,633, a change of 8,556,703 (3.0%).
- Net income of 8,556,703 contributed positively to equity growth.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $8.56 Million | +2.88% |
| Total Change | $- | 2.96% |
Book Value vs Market Value Analysis
This analysis compares Churchill Capital Corp IX Warrant's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.04x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1835.15x to 0.04x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | $0.00 | $0.44 | x |
| 2024-12-31 | $10.05 | $0.44 | x |
| 2025-12-31 | $10.35 | $0.44 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Churchill Capital Corp IX Warrant utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.88%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.03x
- Recent ROE (2.88%) is above the historical average (-102.62%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | -313.77% | 0.00% | 0.00x | 10.82x | $-19.56K |
| 2024 | 3.04% | 0.00% | 0.00x | 1.04x | $-20.11 Million |
| 2025 | 2.88% | 0.00% | 0.00x | 1.03x | $-21.20 Million |
Industry Comparison
This section compares Churchill Capital Corp IX Warrant's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Churchill Capital Corp IX Warrant (CCIXW) | $297.54 Million | -313.77% | 0.03x | $14.04 Million |
| Advent Technologies Holdings Inc (ADNWW) | $-1.79 Million | 0.00% | 0.00x | $26.11 |
| AmpliTech Group Inc (AMPGW) | $500.36K | -19.40% | 0.33x | $754.81 |
| Arko Corp (ARKOW) | $194.89 Million | -22.34% | 8.48x | $23.51 |
| Aris Mining Corporation (ARMN) | $216.71 Million | -1.53% | 1.14x | $3.93 Billion |
| Aberdeen Standard Global Infrastructure Income Fund (ASGI) | $482.92 Million | 1.71% | 0.01x | $472.62 Million |
| Atlas Corp (ATCOL) | $1.06 Billion | 13.71% | 2.46x | $240.21K |
| Auddia Inc (AUUDW) | $420.42K | -2094.93% | 9.47x | $398.90 |
| BriaCell Therapeutics Corp (BCTXW) | $-643.49K | 0.00% | 0.00x | $8.25 |
| Blaize Holdings, Inc. Warrants (BZAIW) | $24.24 Million | -252.48% | 0.99x | $4.00 Million |
About Churchill Capital Corp IX Warrant
Churchill Capital Corp IX does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Churchill Capital Corp IX was incorporated in 2023 and is based in New York, New York.